Stratification variables | Prescribed exercise duration | n | 6 months percent change from baseline | 12 months percent change from baseline | Treatment effecta | Between-group Pb | |
---|---|---|---|---|---|---|---|
Ratio of HIGH:MOD | 95% CI | ||||||
Time at high intensityc | |||||||
<60% prescribed | MODERATE | 17 | −2.0 | −6.4 | 1.06 | 0.93 – 1.21 | 0.40 |
HIGH | 44 | 8.0 | −0.3 | ||||
≥60% prescribed | MODERATE | 41 | −5.1 | −1.5 | 1.01 | 0.88 – 1.17 | 0.85 |
HIGH | 36 | 0.5 | −1.2 | ||||
BMId | |||||||
< 30 | MODERATE | 116 | 15.1 | 16.0 | 0.98 | 0.91, 1.06 | 0.59 |
HIGH | 121 | −4.7 | −4.7 | ||||
≥ 30 | MODERATE | 75 | 11.3 | 3.6 | 1.05 | 0.95, 1.15 | 0.36 |
HIGH | 74 | 7.7 | −1.6 | ||||
VO2max levele | |||||||
< 27.2 ml/kg min | MODERATE | 93 | 12.7 | 2.5 | 1.04 | 0.96, 1.13 | 0.38 |
HIGH | 98 | 3.7 | −2.2 | ||||
≥ 27.2 ml/kg min | MODERATE | 98 | 14.4 | 19.8 | 0.98 | 0.90, 1.06 | 0.57 |
HIGH | 97 | −3.9 | −5.0 | ||||
Total body fatf | |||||||
< 29.7 kg | MODERATE | 94 | 9.1 | 8.9 | 0.98 | 0.90, 1.07 | 0.61 |
HIGH | 99 | −4.7 | −3.8 | ||||
≥ 29.7 kg | MODERATE | 97 | 18.1 | 13.0 | 1.03 | 0.95, 1.12 | 0.48 |
HIGH | 96 | 4.7 | −3.3 |